Based on the ability of TP53 to induce apoptosis, mitochondrial targeted TP53 fusion proteins have been developed to induce intrinsic apoptosis in cancer cells, which may be of relevance in adjuvant therapy for cancer treatment [201, 250]. This evidence concerns the gene TP53 and cancer.